Program Committee

Paola Testori Coggi
Special Advisor, National Technological Cluster on Life Sciences (ALISEI), Former Director General Health and Consumers, European Commission

Bettina Ryll, MD, PhD
Founder, Melanoma Patient Network Europe and Past Chair of the Patient Advocates Working Group, European Society for Medical Oncology, Uppsala, Sweden

Mark Sculpher, PhD
Professor of Health Economics, Centre for Health Economics, University of York, York, UK

Issue Panel/Workshop Review Committee

Alima Almadiyeva
Chief Scientific and Operations Officer, Kazakh Agency for Health Technology Assessment, Astana, Kazakhstan

Páll Jónsson, PhD
Associate Director, Science Policy and Research, National Institute for Health and Care Excellence, Manchester, UK

Amr Makady, PhD
PharmD, Health Economics & Market Access Manager, Johnson & Johnson, Breda, Netherlands

Mirjami Tran Minh
Advisor, Patient Involvement, Association of Cancer Patients in Finland, Helsinki, Finland

Brigitta Monz, MD, MPH, MA
Global Head, Measurement Science, Digital Health Technologies, Roche, Basel, Switzerland

Edit Remak
Partner & Director, Health Economics, Visible Analytics, Budapest, Hungary  

Katarzyna Kolasa, PhD
Head of Health Economics and Healthcare Management Division, Professor Kozminski University, Warsaw, Poland

Andrew Lloyd
Director, Acaster Lloyd Consulting Ltd., London, UK

Research Review Committee

Oriana Ciani, PhD
Associate Professor of Practice, SDA Bocconi School of Management, Milan, Italy, Fulbright Research Scholar, Yale University, CT

David Epstein
Associate Professor, Department of Applied Economics, University of Granada, Granada, Spain

Martin Henriksson
Associate Professor, Linköping University, Linköping, Sweden

Beth Woods
Senior Research Fellow, TEEHTA, Center for Health Economics, University of York, York, UK